C145H163N27O7 — CID 159299180
1-cyclobutyl-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-[1-(2,2-dimethylpropyl)azetidin-3-yl]-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-(1-ethylazetidin-3-yl)-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-(1-methylazetidin-3-yl)-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-[1-(2-methylpropyl)azetidin-3-yl]-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]-1-(1-propan-2-ylazetidin-3-yl)ethanone;2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]-1-(1-propylazetidin-3-yl)ethanone (PubChem CID 159299180) has the molecular formula C145H163N27O7 and a molecular weight of 2396.08 g/mol. Its IUPAC name is 1-cyclobutyl-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-[1-(2,2-dimethylpropyl)azetidin-3-yl]-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-(1-ethylazetidin-3-yl)-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-(1-methylazetidin-3-yl)-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-[1-(2-methylpropyl)azetidin-3-yl]-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]-1-(1-propan-2-ylazetidin-3-yl)ethanone;2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]-1-(1-propylazetidin-3-yl)ethanone.
| Compound Name | 1-cyclobutyl-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-[1-(2,2-dimethylpropyl)azetidin-3-yl]-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-(1-ethylazetidin-3-yl)-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-(1-methylazetidin-3-yl)-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-[1-(2-methylpropyl)azetidin-3-yl]-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]-1-(1-propan-2-ylazetidin-3-yl)ethanone;2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]-1-(1-propylazetidin-3-yl)ethanone |
|---|---|
| PubChem CID | 159299180 |
| Molecular Formula | C145H163N27O7 |
| Molecular Weight | 2396.08 g/mol |
| Exact Mass | 2394.32 |
| IUPAC Name | 1-cyclobutyl-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-[1-(2,2-dimethylpropyl)azetidin-3-yl]-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-(1-ethylazetidin-3-yl)-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-(1-methylazetidin-3-yl)-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;1-[1-(2-methylpropyl)azetidin-3-yl]-2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]ethanone;2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]-1-(1-propan-2-ylazetidin-3-yl)ethanone;2-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]-1-(1-propylazetidin-3-yl)ethanone |
| SMILES | CC(C)CN1CC(C(=O)Cc2cc3cc(-c4cnn(C)c4)ccc3cn2)C1.CC(C)N1CC(C(=O)Cc2cc3cc(-c4cnn(C)c4)ccc3cn2)C1.CCCN1CC(C(=O)Cc2cc3cc(-c4cnn(C)c4)ccc3cn2)C1.CCN1CC(C(=O)Cc2cc3cc(-c4cnn(C)c4)ccc3cn2)C1.CN1CC(C(=O)Cc2cc3cc(-c4cnn(C)c4)ccc3cn2)C1.Cn1cc(-c2ccc3cnc(CC(=O)C4CCC4)cc3c2)cn1.Cn1cc(-c2ccc3cnc(CC(=O)C4CN(CC(C)(C)C)C4)cc3c2)cn1 |
| InChI | InChI=1S/C23H28N4O.C22H26N4O.2C21H24N4O.C20H22N4O.C19H20N4O.C19H19N3O/c1-23(2,3)15-27-13-20(14-27)22(28)9-21-8-18-7-16(5-6-17(18)10-24-21)19-11-25-26(4)12-19;1-15(2)11-26-13-20(14-26)22(27)8-21-7-18-6-16(4-5-17(18)9-23-21)19-10-24-25(3)12-19;1-14(2)25-12-19(13-25)21(26)8-20-7-17-6-15(4-5-16(17)9-22-20)18-10-23-24(3)11-18;1-3-6-25-13-19(14-25)21(26)9-20-8-17-7-15(4-5-16(17)10-22-20)18-11-23-24(2)12-18;1-3-24-12-18(13-24)20(25)8-19-7-16-6-14(4-5-15(16)9-21-19)17-10-22-23(2)11-17;1-22-10-17(11-22)19(24)7-18-6-15-5-13(3-4-14(15)8-20-18)16-9-21-23(2)12-16;1-22-12-17(11-21-22)14-5-6-15-10-20-18(8-16(15)7-14)9-19(23)13-3-2-4-13/h5-8,10-12,20H,9,13-15H2,1-4H3;4-7,9-10,12,15,20H,8,11,13-14H2,1-3H3;4-7,9-11,14,19H,8,12-13H2,1-3H3;4-5,7-8,10-12,19H,3,6,9,13-14H2,1-2H3;4-7,9-11,18H,3,8,12-13H2,1-2H3;3-6,8-9,12,17H,7,10-11H2,1-2H3;5-8,10-13H,2-4,9H2,1H3 |
| InChIKey | LBCMYJGJWLKRMU-UHFFFAOYSA-N |
| XLogP | 21.79 |
| TPSA | 353.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 179 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2396.08 |
| LogP ≤ 5 | 21.79 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 34 |